Jolanda Howe, SVP, GLOBAL CONTROLLER at Mirum Pharmaceuticals, Inc. (MIRM), sold 112,312 shares at $44.33 ($5.0M) on 2025-03-17, disclosed to the SEC on 2025-03-18.
Scheduled sale ($5.0M) by SVP, GLOBAL CONTROLLER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $44.21 | 2,900 | $128K | 2.6% |
| 2 | $44.33 | 50,111 | $2.2M | 44.6% |
| 3 | $44.33 | 50,111 | $2.2M | 44.6% |
| 4 | $44.36 | 1,806 | $80K | 1.6% |
| 5 | $44.36 | 1,806 | $80K | 1.6% |
| 6 | $44.75 | 2,789 |
| $125K |
| 2.5% |
| 7 | $44.75 | 2,789 | $125K | 2.5% |
| Total | $44.35 avg | 112,312 | $5.0M | 100% |
| Filing → |
| MIRM | SELL | 2026-08-05 | $194K | — | Filing → |
| MIRM | SELL | 2026-07-02 | $327K | — | Filing → |
| MIRM | SELL | 2026-06-18 | $264K | — | Filing → |